ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,302Medicare Part D Prescriptions Filled, Including Refills

Rank: 126 out of 2343

$921K Total Retail Price of All Prescriptions

Rank: 166 out of 2343

774 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
33% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 774 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

10% of this provider’s 774 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 14,964 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
LEVOTHYROXINE SODIUM 685 607 1 2
SIMVASTATIN 635 542 2 1
AMLODIPINE BESYLATE 598 518 3 5
METOPROLOL TARTRATE 508 457 4 7
LISINOPRIL 455 400 5 3
OMEPRAZOLE 442 361 6 4
FUROSEMIDE 413 367 7 6
HYDROCODONE-ACETAMINOPHEN 336 249 S3 8 13
POTASSIUM CHLORIDE 327 304 9 18
HYDROCHLOROTHIAZIDE 324 301 10 11
METFORMIN HCL 312 282 11 9
WARFARIN SODIUM 293 257 12 8
GABAPENTIN 293 266 12 16
PANTOPRAZOLE SODIUM 228 187 14 22
ATENOLOL 225 210 15 12
PREDNISONE 219 190 16 37
PRAVASTATIN SODIUM 206 171 17 15
LISINOPRIL-HYDROCHLOROTHIAZIDE 180 174 18 42
INDAPAMIDE 172 169 19 170
LOVASTATIN 164 137 20 47
SERTRALINE HCL 158 138 21 20
CARVEDILOL 154 121 22 27
ALLOPURINOL 151 134 23 31
ATORVASTATIN CALCIUM 145 137 24 10
TAMSULOSIN HCL 144 132 25 29
FLUOXETINE HCL 143 99 26 82
AMOXICILLIN 142 119 27 118
CLOPIDOGREL 140 128 28 26
PAROXETINE HCL 139 119 29 66
ISOSORBIDE MONONITRATE ER 133 133 30 32
DONEPEZIL HCL 129 127 31 21
NAMENDA 127 127 32 36
GLIMEPIRIDE 123 108 33 45
LOSARTAN POTASSIUM 122 108 34 19
DIGOXIN 119 104 35 35
SPIRIVA 116 107 36 48
NEXIUM 114 103 37 33
HYDRALAZINE HCL 112 112 38 92
ZETIA 110 105 39 52
OXYCODONE-ACETAMINOPHEN 108 103 S2 40 49
PLAVIX 108 101 40 38
ALENDRONATE SODIUM 106 106 42 28
METOPROLOL SUCCINATE 106 100 42 14
ESCITALOPRAM OXALATE 95 95 44 55
TRAZODONE HCL 95 64 44 53
CITALOPRAM HBR 89 85 46 17
BUSPIRONE HCL 87 67 47 146
LOSARTAN-HYDROCHLOROTHIAZIDE 86 70 48 64
FLUTICASONE PROPIONATE 85 77 49 46
POLYETHYLENE GLYCOL 3350 85 82 49 54
OXYCODONE HCL 84 36 S2 51 67
SINGULAIR 83 69 52 100
TRAMADOL HCL 81 56 53 25
AGGRENOX 79 79 54 174
CLONIDINE HCL 75 55 55 70
BENICAR 75 75 55 93
SULFAMETHOXAZOLE-TRIMETHOPRIM 75 65 55 120
RISPERIDONE 73 69 58 61
EVISTA 71 71 59 128
KLOR-CON M20 71 64 59 44
GEMFIBROZIL 70 64 61 133
MECLIZINE HCL 70 61 61 103
AZITHROMYCIN 70 54 61 39
GLYBURIDE 67 60 R 64 62
ADVAIR DISKUS 67 41 64 34
CELEBREX 66 57 66 71
AMLODIPINE BESYLATE-BENAZEPRIL 66 62 66 59
KLOR-CON 10 64 64 68 134
CYMBALTA 63 31 69 74
DICLOFENAC SODIUM 63 46 69 155
VERAPAMIL ER 62 62 71 95
JANUVIA 61 51 72 50
MORPHINE SULFATE ER 61 36 S2 72 142
SYNTHROID 61 58 72 40
IBUPROFEN 60 35 75 75
VITAMIN D2 60 57 75 369
AMITRIPTYLINE HCL 60 29 R 75 117
CRESTOR 59 52 78 30
SPIRONOLACTONE 59 52 78 65
MONTELUKAST SODIUM 59 47 78 181
LANTUS 58 42 81 51
DIOVAN 58 58 81 23
TOPIRAMATE 58 15 81 220
TRIAMTERENE-HCTZ 55 44 84 57
VENLAFAXINE HCL ER 54 11 85 87
QUINAPRIL HCL 54 49 85 73
CYCLOBENZAPRINE HCL 54 30 R 85 109
ZOLPIDEM TARTRATE 53 50 88 24
DETROL LA 53 53 88 150
CEPHALEXIN 52 48 90 111
PROPRANOLOL HCL 52 46 90 132
COLCRYS 51 47 92 166
VENTOLIN HFA 51 42 92 79
TERAZOSIN HCL 51 51 92 143
TRIAMCINOLONE ACETONIDE 50 47 95 137
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 18, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.